(Q44308423)
Statements
Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study (English)
Laura G Estévez
José Miguel Cuevas
Antonio Antón
Jesús Florián
José Manuel López-Vega
Amalia Velasco
Francisco Lobo
Ana Herrero
1 February 2003